Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis Japan’s Office Raided by Prosecutors, Adding to Probes
Bloomberg
Thu, 06/12/14 - 11:13 am
Tags:
Novartis, Japan, Diovan
IPO Stock Watch: Receptos Soars On MS Drug Results
Investors.com
Tue, 06/10/14 - 07:22 pm
Tags:
IPOs, MS, multiple sclerosis, Receptos, RPC1063, Novartis, Gilenya
How Many? Novartis Says 10,000 Side Effect Cases Were Never Filed
WSJ Online
Tue, 06/10/14 - 04:49 pm
Tags:
side effects, adverse events, Novartis, Japan
AstraZeneca: Pfizer Wants It, So Should You
Seeking Alpha
Tue, 06/10/14 - 10:38 am
Tags:
Pfizer, AstraZeneca, Novartis, Teva Pharmaceuticals, M&A
Biopharmaceutical Industry Consolidation Diminishes Future Drug Discovery
Forbes
Tue, 06/10/14 - 09:38 am
Tags:
R&D, M&A, Pfizer, Wyeth, GSK, Novartis
FirstWord List: Top 15 pharma and lead product dependency
First Word Pharma
Mon, 06/9/14 - 10:35 am
Tags:
Teva, AbbVie, Boehringer Ingelheim, GSK, Sanofi, Amgen, Eli Lilly, JNJ, AstraZeneca, Roche, Novartis, Merck, Pfizer, Takeda, Bristol-Myers Squibb
ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects
Yahoo/Benzinga
Wed, 06/4/14 - 03:18 pm
Tags:
Fertility, cancer, ASCO, Zoladex, AstraZeneca, Novartis, Zometa
Novartis granted orphan status for treatment of diffuse large B-cell lymphoma
Yahoo/Fly on the Wall
Wed, 06/4/14 - 09:25 am
Tags:
orphan drugs, Novartis, diffuse large B-cell lymphoma, Afinitor, FDA
Novartis says Zykadia shrank tumors in majority of patients with ALK+ NSCLC
The Fly on the Wall
Mon, 06/2/14 - 06:10 pm
Tags:
Novartis, Zykadia, non-small cell lung cancer
Cancer Conference Winners And Losers
Forbes
Mon, 06/2/14 - 10:38 am
Tags:
ASCO, GSK, Puma Biotechnology, Merck, Roche, Bristol-Myers Squibb, Kite, Novartis, Juno Therapeutics, Eli Lilly, Clovis Oncology, AstraZeneca
Novartis bone marrow drug improves progression-free survival
Yahoo/Reuters
Mon, 06/2/14 - 10:04 am
Tags:
Novartis, LBH589, Multiple Myeloma, ASCO
Novartis nabs Merck exec as president of oncology business
The Pharma Letter
Sun, 06/1/14 - 12:29 pm
Tags:
Novartis, Merck
Italy to seek $1.6 billion damages from Roche, Novartis
Marketwatch
Thu, 05/29/14 - 01:14 pm
Tags:
Italy, Roche, Novartis, antitrust, Lucentis
Novartis MS Drug Helps Traumatic Memories Fade in Mice
Bloomberg
Mon, 05/26/14 - 08:35 am
Tags:
Novartis, PTSD, post traumatic stress disorder, Gilenya
Novartis, Boehringer vie for COPD market share with combo meds
Fierce Biotech
Thu, 05/22/14 - 11:57 am
Tags:
COPD, Novartis, Boehringer Ingelheim, LAMA/LABA
Acura Pharma announces settlement of patent litigation with Sandoz
The Fly on the Wall
Thu, 05/22/14 - 08:28 am
Tags:
Sandoz, Novartis, Acura Pharmaceuticals, patents, Aversion, Oxceta
Ophthotech deal with Novartis leaves Fovista well-positioned, says Stifel
The Fly on the Wall
Tue, 05/20/14 - 11:24 am
Tags:
Ophthotech, Fovista, Novartis, wet age-related macular degeneration, wet-AMD
Novartis-backed Sorbent grabs first tranche in $15M heart therapy round
Fierce Biotech
Fri, 05/16/14 - 10:13 am
Tags:
Sorbent Therapeutics, Novartis, CLP-1001
Proteon banks $45M for vascular drug with Novartis in the rearview
Fierce Biotech
Fri, 05/16/14 - 10:11 am
Tags:
Proteon, Novartis, PRT-201
Novartis Fails to Win U.S. Approval for Serelaxin Heart Drug
Bloomberg
Fri, 05/16/14 - 07:54 am
Tags:
Novartis, serelaxin, heart failure

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.